Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

TARGETMOL CHEMICALS INC VX-702 10MG
SDP

Catalog No. 502577102
Encompass_Preferred

Also available in 25mg 50mg and bulk. Please contact Fisher for quotes. VX-702 is a highly specific p38α MAPK inhibitor 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases specifically rheumatoid arthritis (RA). purity: 99%

Catalog No. 50-257-7102 Supplier TARGETMOL CHEMICALS INC Supplier No. T251310MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Also available in 25mg 50mg and bulk. Please contact Fisher for quotes. VX-702 is a highly specific p38α MAPK inhibitor 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases specifically rheumatoid arthritis (RA). purity: 99%

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.